HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE COVER ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Submit a letter to the editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bilimoria, M. M. Articles by Morrow, M. Search for Related Content PubMed PubMed Citation Articles by Bilimoria, M. M. Articles by Morrow, M.

CA: A Cancer Journal for Clinicians, Vol 45, Issue 5 263-278, Copyright © 1995 by American Cancer Society

ARTICLES

The woman at increased risk for breast cancer: evaluation and management strategies

M. M. Bilimoria and M. Morrow
Department of Surgery, Northwestern University Medical School, Chicago, Illinois, USA.

Increased understanding of risk factors for breast cancer, especially the identification of genes associated with a predisposition to breast cancer, has focused attention on the issue of breast cancer prevention. At present, the only clinically available method of breast cancer prevention is prophylactic mastectomy. However, there are no absolute indications for its use, and it is not often appropriate in relation to actual risk for disease. This article reviews what is known about major breast cancer risk factors, reviews the available data on prophylactic mastectomy, and discusses current strategies for the management of the woman at increased risk for breast cancer.

This article has been cited by other articles:

				A. Soran, J. Falk, M. Bonaventura, D. Keenan, G. Ahrendt, and R. Johnson Is Routine Sentinel Lymph Node Biopsy Indicated in Women Undergoing Contralateral Prophylactic Mastectomy? Magee-Womens Hospital Experience Ann. Surg. Oncol., February 1, 2007; 14(2): 646 - 651. [Abstract] [Full Text] [PDF]

				L. J. Herrinton, W. E. Barlow, O. Yu, A. M. Geiger, J. G. Elmore, M. B. Barton, E. L. Harris, S. Rolnick, R. Pardee, G. Husson, et al. Efficacy of Prophylactic Mastectomy in Women With Unilateral Breast Cancer: A Cancer Research Network Project J. Clin. Oncol., July 1, 2005; 23(19): 4275 - 4286. [Abstract] [Full Text] [PDF]

				S. K. McDonnell, D. J. Schaid, J. L. Myers, C. S. Grant, J. H. Donohue, J. E. Woods, M. H. Frost, J. L. Johnson, D. L. Sitta, J. M. Slezak, et al. Efficacy of Contralateral Prophylactic Mastectomy in Women With a Personal and Family History of Breast Cancer J. Clin. Oncol., October 1, 2001; 19(19): 3938 - 3943. [Abstract] [Full Text]

				H. Meijers-Heijboer, B. van Geel, W. L.J. van Putten, S. C. Henzen-Logmans, C. Seynaeve, M. B.E. Menke-Pluymers, C. C.M. Bartels, L. C. Verhoog, A. M.W. van den Ouweland, M. F. Niermeijer, et al. Breast Cancer after Prophylactic Bilateral Mastectomy in Women with a BRCA1 or BRCA2 Mutation N. Engl. J. Med., July 19, 2001; 345(3): 159 - 164. [Abstract] [Full Text] [PDF]

				L. A. Newman, H. M. Kuerer, K. K. Hunt, G. Vlastos, F. C. Ames, M. I. Ross, and S. E. Singletary Educational Review: Role of the Surgeon in Hereditary Breast Cancer Ann. Surg. Oncol., May 1, 2001; 8(4): 368 - 378. [Abstract] [Full Text] [PDF]

				I. Unic, L. C.G. Verhoef, P. F.M. Stalmeier, and W. A.J. Van Daal Prophylactic Mastectomy or Screening in Women Suspected to Have the BRCA1/2 Mutation: A Prospective Pilot Study of Women's Treatment Choices and Medical and Decision-analytic Recommendations Med Decis Making, July 1, 2000; 20(3): 251 - 262. [Abstract] [PDF]

				L. C. Hartmann, D. J. Schaid, J. E. Woods, T. P. Crotty, J. L. Myers, P.G. Arnold, P. M. Petty, T. A. Sellers, J. L. Johnson, S. K. McDonnell, et al. Efficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast Cancer N. Engl. J. Med., January 14, 1999; 340(2): 77 - 84. [Abstract] [Full Text] [PDF]